Aug 4, 2026 07:00AM
Jun 17, 2026 04:30PM
Jun 17, 2026 04:30PM
May 11, 2026 06:25AM
May 7, 2026 08:00AM
May 7, 2026 08:00AM
Mar 3, 2026 08:00AM Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
Feb 26, 2026 06:00AM
Oct 30, 2025 04:16PM
Oct 30, 2025 04:15PM
Oct 20, 2025 08:00AM
Sep 4, 2025 08:00AM
Jul 3, 2025 07:39AM
May 8, 2025 06:03AM Barclays Upgrades Certara Inc. (CERT) to Overweight
May 5, 2025 04:15PM
Apr 14, 2025 08:16AM
Apr 14, 2025 08:15AM
Apr 1, 2025 08:00AM
Apr 1, 2025 08:00AM
Apr 1, 2025 08:00AM
Dec 2, 2024 04:15PM Certara Showcases 2024 Research Wins With Over 100 Papers Published
Sep 24, 2024 08:00AM
Sep 18, 2024 08:00AM
Sep 18, 2024 08:00AM
Aug 15, 2024 04:15PM
Aug 15, 2024 04:15PM
Nov 21, 2023 04:30PM
Nov 21, 2023 04:30PM Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development  
Nov 21, 2023 04:30PM
Sep 19, 2023 08:15AM
Aug 29, 2023 08:15AM
Aug 29, 2023 08:15AM
Aug 3, 2023 09:00PM
Apr 27, 2023 08:00AM
Apr 27, 2023 08:00AM Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year
Mar 21, 2023 08:00AM
Mar 7, 2023 08:00AM
Mar 7, 2023 08:00AM
Aug 5, 2022 08:00AM
Aug 5, 2022 08:00AM
Jun 28, 2022 08:00AM
Jun 28, 2022 08:00AM Certara Introduces New Simcyp™ Discovery Simulator for Early-Stage and Translational Drug Development
Jun 21, 2022 08:00AM
Feb 23, 2022 04:31PM
Feb 23, 2022 04:30PM
Feb 23, 2022 04:30PM
Feb 15, 2022 04:30PM
Feb 15, 2022 04:30PM
Dec 21, 2021 08:02AM Certara, Inc. (CERT) Announces FDA Renewal and Expansion of Certara’s Biosimulation Software for Reviewing Regulatory Submissions
Dec 21, 2021 08:00AM

328,333 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All